Recruiting studies: Progressive Brain Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Palbociclib and Pembrolizumab In Central Nervous System Metastases
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT02896335 Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastase
Phase 2 · 1 location(s) · Medical University of Vienna · NCT05866432 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090 Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Phase 2/Phase 3 · 1 location(s) · Institute of Psychiatry and Neurology, Warsaw · NCT05961644 Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Canc
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07505173 Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07383649 Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Act
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05700721

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.